Opinion|Videos|May 22, 2024
Overview of Clinical Trials for New Imaging Options for Kidney Cancer
Author(s)Neal Shore, MD, FACS, Brian M. Shuch, MD
Urologists review clinical trials investigating new imaging options in kidney cancer, including the ZIRCON study looking at girentuximab.
Advertisement
Episodes in this series
Advertisement
Related to this article
The investigational HIF-2α inhibitor casdatifan demonstrated antitumor activity as monotherapy and in combination regimens across the ARC-20 platform study.
Advertisement
Advertisement
Trending on Urology Times
1
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
2
How PSMA-PET shapes staging and recurrence workup in prostate cancer
3
ESMO 2026: Key presentations across genitourinary oncology
4
FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC
5